Similar Articles
1261 Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation
1262 Multimodal treatment of hepatocellular carcinoma on cirrhosis: An update
1263 Radiofrequency ablation of hepatocellular carcinoma sized > 3 and ≤ 5 cm: Is ablative margin of more than 1 cm justified?
1264 Differentiation between dysplastic nodule and early-stage hepatocellular carcinoma: The utility of conventional MR imaging
1265 Massive upper gastrointestinal hemorrhage due to invasive hepatocellular carcinoma and hepato-gastric fistula
1266 Association between Ras association domain family 1A promoter methylation and hepatocellular carcinoma: A meta-analysis
1267 Surveillance for hepatocellular carcinoma in chronic liver disease: Evidence and controversies
1268 Chemoprevention of hepatocellular carcinoma in patients with hepatitis C virus related cirrhosis
1269 Advanced hepatocellular carcinoma responds to MK615, a compound extract from the Japanese apricot “Prunus mume”
1270 Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA